That's crucial, because the method a protein in the human body folds figures out if a pharmaceutical will be able to bind to that protein and work. To put it simply, we have to understand how these proteins fold if we desire a drug to work. Historically, this has been an experimental procedure (brownstone research stock). Today, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it much simpler to create drugs that do what they're designed to do. This was an advancement almost no one saw. But it's going to have extensive implications for treating illness. I predict that Alpha, Fold will be 98% accurate by the end of 2021.
And, obviously, there will be a lot of financial investment opportunities in this area, too. Shifting topics It's going to be an excellent year for bitcoin. I'm bullish on it in 2021 (jeff brown genetic sequencer stock). That said, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be surprised if it drew back maybe substantially before going higher - jeff brown genetic sequencing stock. I've been covering bitcoin for a very long time now. Among the first research study reports I ever published was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial recommendation, I titled my report "What's the Big Offer With Bitcoin?" That shows you where the conversation was at the time. We were mainly informing readers. But that's not the huge question any longer. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, specific niche business. Mass, Mutual is a relied on 170-year-old institution. So think of that. In 5 years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
Which's a big reason I'm bullish on it this year. angel investor. Regards, Jeff Brown, Editor, The Bleeding Edge I have a perk prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These companies raised a total of $172 billion. That's an all-time high beating the previous yearly record by 43%. I anticipate 2021 will be another record year in IPOs. There are numerous terrific private business on the brink of striking the public markets And I have actually been working on a brand-new method for you to invest even prior to these companies go public.
This chance has been developing over the last few years. I can't wait to inform you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to learn all the information. Go right here to schedule your area free of charge.
Emma Walsh here, handling editor of the Diary. Regular Diary readers understand that tech isn't our usual beat (artificial intelligence). And when it concerns tech investing, we leave it to the professionals. The good news is, we have several such professionals in our Rolodex. Our coworker Jeff Brown will recognize to our long time readers. He is among the most accomplished tech investing experts we know (jeff brown tech stock 2021). In reality, he had numerous triple-digit returns in his Brownstone Research study portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take a look at the huge photo and forecast what's just around the corner.
That includes things like 5G networks, biotech, artificial intelligence, and far more. These trends are experiencing exponential growth and creating incredible chances for financiers. I desire to make sure all our readers are prepared for what's next. And with that in mind, let me draw the picture of what I see can be found in the next 12 months Our brand-new 5G (fifth-generation) cordless networks are a topic I have actually been covering for years now. jeff brown biotech stocks. However despite what lots of readers may believe, this is a trend that's simply getting going. Although the COVID-19 pandemic interrupted supply chains last year, an outstanding 250 million 5G-enabled gadgets were still offered.
And all of this ultimately caused Apple postponing the release of the 5G-enabled i, Phone 12 by 2 months (brownstone research). Losing 2 months of production and sales actually impacts the number of 5G gadgets are offered in the calendar year. When you consider all of that, offering 250 million units is impressive. More significantly, the hold-ups triggered by the pandemic created a lot of pent-up need. And that need is now going to be pressed into 2021. In fact, I anticipate that more than 500 million 5G gadgets will be shipped in 2021 - jeff brown stock predictions 2021. Which's not my only 5G prediction When I have actually discussed 5G in the past, I have actually explained its 3 different phases.
In Phase Two, 5G devices go on sale. 5G phones and other products start to reach consumers. And in Phase Three, 5G services start to be used (jeff brown 2021 stock picks). That's when we start to see applications working on 5G networks. Think about things like huge multiplayer video games over a cellphone. That's not possible with 4G. It will be with 5G. And my 2nd 5G prediction for 2021 is that we will begin Phase 3 by this summer season. This starts something of a virtuous cycle: The majority of individuals don't truly appreciate the innovation. But they will care if there are amazing applications that can only be accessed with a 5G phone.
That results in more 5G apps being established. In truth, 5G is going to open up a suite of incredible applications: self-driving cars and trucks, the Internet of Things, robotic surgery, and more. All of these technologies require 5G. The investment opportunities going forward will be huge. Stepping far from 5G, the next crucial technology I anticipate in 2021 is CRISPR hereditary editing. CRISPR represents "clustered routinely interspaced short palindromic repeat." It's a mouthful. However it's one of the most exciting developments in biotechnology. At a high level, CRISPR is an innovation that can edit our hereditary makeup as if it were software.
The program can crash or not operate correctly. CRISPR uses a similar idea but with our hereditary code. "Typos" in our genome can result in disease. CRISPR can fix these "typos." For many years, CRISPR was mostly a niche innovation that wasn't well understood. And during that time, there were truly only 3 companies operating in this area. But things are altering. CRISPR is no longer just theoretical. We're seeing real results. We're dealing with diseases and seeing that this innovation simply works. And as a result, a "2nd crop" of early-stage CRISPR companies is going public and delivering unbelievable returns. This entire industry is efficiently a greenfield opportunity.
There's room for lots of companies to exist in this area. united arab emirates. And there will be more. That's my prediction for CRISPR in 2021. I predict that two or three more hereditary editing business will hold their IPOs. Sticking to biotechnology, we are seeing amazing things occurring at the convergence of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, just announced at the end of 2020 that its newest Alpha, Fold software can precisely forecast the folding of a protein based entirely on its amino acid sequence with 92. 4% precision. That is very important because the method a protein in the human body folds identifies if a pharmaceutical will be able to bind to that protein and work.
Historically, this has been an experimental process. Today, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it much simpler to develop drugs that do what they're designed to do. And here's my next prediction. I anticipate that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one but several drug treatments produced using this innovation. This was among those breakthroughs that practically nobody discovered. But it's going to have profound ramifications for curing illness. And, obviously, there will be a lot of financial investment opportunities in this area, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be surprised if it pulled back possibly significantly prior to going greater. I've been covering bitcoin for a very long time now. One of the first research study reports I ever published was on bitcoin - jeff brown biotech genome sequencing. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on investment for anyone who followed my recommendation. But at the time of that initial suggestion, I titled my report, "What's the Big Deal With Bitcoin?" That shows you where the conversation was at the time.
But no one is asking that concern any longer. Now, we're seeing institutional cash finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, niche enterprise. angel investor. Mass, Mutual is a 150-year-old institution. So consider that. In five years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a big reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more reward forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and declares the info depends on date since February 2021, however we might not separately validate this claim. Provided Jeff Brown's past, he likely has a considerable net worth, however we can't hammer down an accurate figure at this minute. Brown is best known for his sage-like ability to pick winning innovation stocks. He spent more than 25 years looking into technology business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience provides him an excellent point of view on the market. He's always on the hunt for brand-new chances, and he shares a number of his best choices in the Future Report.
That's full marks, however it's not ridiculously reasoned. Brown has an outstanding track record as a stock-picker, and he successfully predicted some of the greatest financial events of the previous 20 years. Although he does not appear to release his choices to the public, the service's success is a direct indicator of Brown's stock-picking expertise. Nobody on Wall Street gets it best each time, however Jeff Brown's accurate forecasts have made him legions of dedicated followers. That says a lot about his ability. The Future Report is released by Brownstone Research study, a popular monetary research study publisher. Brownstone Research provides a number of research study services with a variety of expertises - jeff brown top biotech 2020.
The company is also affiliated with Bonner & Partners, another well-respected research publisher - united arab emirates. On its site, Brownstone says its mission is to offer retail financiers with professional-grade research study: "For too long, the best investment research study has actually not been offered to individual financiers. It has been typically booked for financial investment banks, hedge funds, personal equity, and high-net-worth clients. tech stock. The objective of Brownstone Research is to make that sort of exclusive research study readily available to any investors looking to acquire an edge in the markets. The goal is basic to provide distinct and profitable financial investment research found no place else." -Brownstone Research study site excerpt from the Jeff Brown is the founder of Brownstone Research study, and he also acts as the firm's Chief Financial investment Analyst.
With Brown directing the ship, Brownstone Research is a powerhouse publisher with lots to use its customers. After decades of stable success at the helm of top-tier business like Tesla and Space, X, Elon Musk is a household name throughout most of America. If you understand even a bit about the market, you know that he has a reputation as a King Midas of sorts. future report. Whatever he touches relies on gold! Jeff is aware of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next big task.
In reality, Brown believes S.A.V. jeff brown investment prediction. might be "the most significant pattern of the 2020s, and he's not alone. Have a look at these quotes from other well-known S.A.V. bulls: Elon's next huge act will be marrying two innovative technologies: expert system and electrical automobiles. Musk hopes the mix will help him develop the first fully-autonomous, self-driving automobiles ever. It's absolutely nothing short of the automobile industry's Holy Grail. As you know, electric automobiles and self-driving vehicle stocks have been huge this year, but the Wall Street machine has actually approved hype without much concrete outcome. Regardless of a drastic increase in competition over the past few years, Brown still believes Musk has the very best chance of putting it all together.
tech might be the magic string that connects everything together. S.A.V. represents Shared Autonomous Automobile, and it might be the future of transport. Essentially, this technology would allow you to rent your car as an autonomous, self-driving taxi when you're not using it. You simply leave the car and press a button on an app that tells the automobile to "join the fleet." Next thing you understand, you're relaxing on your couch while your cars and truck shuttles ride-sharers around town. Best of all, you get to keep a hefty piece of the earnings. It sounds ridiculous, however it might be closed than you think.